MC
Marc Cohen
Founder of Regenacy Pharmaceuticals
McLean, Virginia
Overview
Marc Cohen is a highly successful biotech and software entrepreneur currently serving as the CEO and Chairman of multiple companies, including Cobro Ventures, C4 Therapeutics, and Frequency Therapeutics. With a strong track record of founding and leading innovative companies in the biotech and software sectors, he has successfully invested in companies like NextRNA Therapeutics and Mana Therapeutics, contributing to their growth and success.
Work Experience
CEO and Co-Founder
2012 - Current
Executive Chairman and co-Founder
2015
Chairman
2015
Executive Chairman and Co-Founder
2016
Chairman and Co-Founder
2014
CEO and Co-Founder
2014
Insta-organize anything.
Chairman and Co-Founder
2008 - 2016
Sold to Celgene.
Acetylon Pharmaceuticals manufactures small molecule drugs to realize the therapeutic potential of histone deacetylase.
Raised $151,250,000.00 from Celgene and Celgene.
Founder and former Chairman and CEO
1986 - 2012
Co-founder of OPNET Technologies (Nasdaq: OPNT) with brother Alain Cohen. Sold the company to Riverbed Technology (Nasdaq: RVBD) in December 2012.
CEO
1986 - 2012